Hellenic Institute For The Study Of Sepsis

This study tests a drug called emapalumab in 75 adults with sepsis, a life-threatening response to infection. The drug blocks a protein called interferon-gamma that may drive severe inflammation. Researchers want to see if it improves organ function and find the best dose. Partic…

This study tests a new approach for treating severe infections (sepsis) in intensive care units. It uses rapid tests to quickly identify the bacteria causing the infection and their antibiotic resistance, along with a blood marker called procalcitonin. The goal is to see if this …